Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample

References

• Slade T, Johnston A, Oakley Browne MA, Andrews G, Whiteford H. 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry 2009; 43:594–605.
   PubMed Web of Science ®Google Scholar
• Andrews G, Tolkien II Team. Tolkien II: a needs-based, costed stepped-care model for mental health services. Sydney: World Health Organization Collaborating Centre for Classification of Mental Health, 2007.
   Google Scholar
• Bandelow B, Zohar J, Hollander E, Kasper S, Jürgen Möller H. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive–compulsive and posttraumatic stress disorders. World Journal of Biological Psychiatry 2008; 9:248–312.
   PubMed Web of Science ®Google Scholar
• Mitte K, Noack P, Steil R, Hautzinger M. A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. J Clin Psychopharmacol 2005; 25:141–150.
   PubMed Web of Science ®Google Scholar
• NICE. Guidance on the use of zalepon, zolpidem and zoplicone for the short-term management of insomnia. London: National Institute for Health and Clinical Excellence, 2004.
   Google Scholar
• Hollingworth SA, Burgess PM, Whiteford HA. Affective and anxiety disorders: prevalence, treatment and antidepressant medication use. Aust N Z J Psychiatry 2010; 44:513–519.
   PubMed Web of Science ®Google Scholar
• Hollingworth S, Siskind D. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Saf 2010; 19:280–288.
   PubMed Web of Science ®Google Scholar
• Burgess PM, Pirkis JE, Slade TN, Johnston AK, Meadows GN, Gunn JM. Service use for mental health problems: findings from the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2009; 43:615–623.
   PubMed Web of Science ®Google Scholar
• Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom 2008; 77:83–92.
   PubMed Web of Science ®Google Scholar
• Goldney R, Bain M. Prevalence of psychotropic use in a South Australian population. Australas Psychiatry 2006; 14:379–383.
   PubMedGoogle Scholar
• Page AN, Swannell S, Martin G, Hollingworth S, Hickie IB, Hall WD. Sociodemographic correlates of antidepressant utilisation in Australia. Med J Aust 2009; 190:479–483.
   PubMed Web of Science ®Google Scholar
• Lagnaoui R, Depont F, Fourrier A, . Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol 2004; 60:523–529.
   PubMed Web of Science ®Google Scholar
• John U, Baumeister SE, Volzke H, Meyer C, Ulbricht S, Alte D. Sedative, hypnotic, anxiolytic and opioid medicament use and its co-occurrence with tobacco smoking and alcohol risk drinking in a community sample. BMC Public Health 2007; 7:337.
   Google Scholar
• Colman I, Croudace TJ, Wadsworth ME, Jones PB. Factors associated with antidepressant, anxiolytic and hypnotic use over 17 years in a national cohort. J Affect Disord 2008; 110:234–240.
   PubMed Web of Science ®Google Scholar
• Wells KB, Kamberg C, Brook R, Camp P, Rogers W. Health status, sociodemographic factors, and the use of prescribed psychotropic drugs. Med Care 1985; 23:1295–1306.
   PubMed Web of Science ®Google Scholar
• Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch Intern Med 1994; 154:1235–1240.
   PubMedGoogle Scholar
• Blennow G, Romelsjo A, Leifman H, Leifman A, Karlsson G. Sedatives and hypnotics in Stockholm: social factors and kinds of use. Am J Public Health 1994; 84:242–246.
   PubMed Web of Science ®Google Scholar
• Beck CA, Patten SB, Williams JVA, . Antidepressant utilisation in Canada. Soc Psychiatry Psychiatr Epidemiol 2005; 40:799–807.
   PubMed Web of Science ®Google Scholar
• Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002; 63:817–825.
   PubMed Web of Science ®Google Scholar
• Australian Bureau of Statistics. National Health Survey: users’ guide - electronic publication, 2004–05. Canberra: Australian Bureau of Statistics, 2006.
   Google Scholar
• World Health Organization. International statistical classification of diseases and related health problems, 10th revision. Geneva: World Health Organization, 1992.
   Google Scholar
• Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry 1999; 56:921–926.
   PubMed Web of Science ®Google Scholar
• Slade T, Watson D. The structure of common DSM-IV and ICD-10 mental disorders in the Australian general population. Psychol Med 2006; 36:1593–1600.
   PubMed Web of Science ®Google Scholar
• Teesson M, Slade T, Mills K. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2009; 43:606–614.
   PubMed Web of Science ®Google Scholar
• Kessler R, Mroczek, D. Final versions of our Non-specific Psychological Distress Scale. Memo dated March 10 1994. Ann Arbor, MI: Survey Research Center for Social Research, University of Michigan, 1994.
   Google Scholar
• Australian Bureau of Statistics. Information paper: use of the Kessler Psychological Distress Scale in ABS health surveys, Australia, 2001. Canberra: Australian Bureau of Statistics, 2003.
   Google Scholar
• Hawthorne G, Richardson J, Osborne R, McNeil H. The Assessment of Quality of Life (AQoL) instrument: construction, initial validation and utility scaling. Working paper 76. Melbourne: Centre for Health Program Evaluation, 1997.
   Google Scholar
• National Health Priority Action Council. Future directions of the National Health Priority Areas initiative. Report to the Australian Health Ministers’ Advisory Council October 2002. Canberra: Department of Health and Ageing, 2002.
   Google Scholar
• Australian Bureau of Statistics. Information paper: an introduction to socio- economic indexes for areas (SEIFA), 2006. Canberra: Australian Bureau of Statistics, 2008.
   Google Scholar
• Australian Bureau of Statistics. Technical manual: National Survey of Mental Health and Wellbeing, confidentialised unit record files 2007. Canberra: Australian Bureau of Statistics, 2009.
   Google Scholar
• StataCorp. Stata Statistical Software: Release 11. StataCorp; 2009.
   Google Scholar
• Australian Bureau of Statistics. 2007–2008 National Health Survey: summary of results. Canberra: Australian Bureau of Statistics, 2009.
   Google Scholar
• Scott KM, Von Korff M, Alonso J, . Mental–physical co-morbidity and its relationship with disability: results from the World Mental Health Surveys. Psychol Med 2009; 39:33–43.
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health and Ageing. Australian statistics on medicine 2008. Canberra: Commonwealth of Australia, 2009.
   Google Scholar
• Alonso J, Angermeyer MC, Bernert S, . Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004:55–64.
   Google Scholar
• Merikangas K, Ames M, Cui L, . The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry 2007; 64:1180–1188.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. Mental health services in Australia, 2006–07. Canberra: Australian Institute of Health and Welfare, 2009.
   Google Scholar
• Australian Bureau of Statistics. 2004–2005 National Health Survey: summary of results Australia. Canberra: Australian Bureau of Statistics, 2006.
   Google Scholar
• Bebbington PE, Brugha TS, Meltzer H, . Neurotic disorders and the receipt of psychiatric treatment. Psychol Med 2000; 30:1369–1376.
   PubMedGoogle Scholar
• Culberson JW, Ziska M. Prescription drug misuse/abuse in the elderly. Geriatrics 2008; 63:22–31.
   PubMed Web of Science ®Google Scholar
• Reavley NJ, Cvetkovski S, Jorm AF, Lubman DI. Help-seeking for substance use, anxiety and affective disorders among young people: results form the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2010; 44:729–735.
   PubMed Web of Science ®Google Scholar
• Parslow RA, Jorm AF. Who uses mental health services in Australia? An analysis of data from the National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2000; 34:997–1008.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Demler O, Frank RG, . Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005; 352:2515–2523.
   PubMed Web of Science ®Google Scholar
• Wang PS, Demler O, Olfson M, Pincus HA, Wells KB, Kessler RC. Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry 2006; 163:1187–1198.
   PubMed Web of Science ®Google Scholar
• Bramesfeld A, Grobe T, Schwartz FW. Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany. Soc Psychiatry Psychiatr Epidemiol 2007; 42:740–746.
   Google Scholar
• Parslow RA, Jorm AF. Predictors of types of help provided to people using services for mental health problems: an analysis of the Australian National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2001; 35:183–189.
   PubMed Web of Science ®Google Scholar
• Issakidis C, Andrews G. Who treats whom? An application of the Pathways to Care model in Australia. Aust N Z J Psychiatry 2006; 40:74–86.
   PubMed Web of Science ®Google Scholar
• Harman JS, Edlund MJ, Fortney JC. Disparities in the adequacy of depression treatment in the United States. Psychiatr Serv 2004; 55:1379–1385.
   PubMed Web of Science ®Google Scholar
• Issakidis C, Andrews G. Service utilisation for anxiety in an Australian community sample. Soc Psychiatry Psychiatr Epidemiol 2002; 37:153–163.
   PubMed Web of Science ®Google Scholar
• Morin C, Bootzin R, Buysse D, Edinger J, Espie C, Lichstein K. Psychological and behavioral treatment of insomnia:update of the recent evidence (1998–2004). Sleep 2006; 29:1398–1414.
   PubMed Web of Science ®Google Scholar